Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 1,685.63 | 1,523.67 | 1,668.83 | 1,544.37 |
Total Revenue | 1,685.63 | 1,523.67 | 1,668.83 | 1,544.37 |
Costof Revenue Total | 1,202.24 | 1,317.40 | 1,369.51 | 1,285.73 |
Gross Profit | 483.39 | 206.27 | 299.33 | 258.64 |
Selling/ General/ Admin Expenses Total | 84.67 | 153.26 | 140.79 | 148.40 |
Depreciation/ Amortization | 60.72 | 59.12 | 56.97 | 60.25 |
Other Operating Expenses Total | 245.62 | -0.91 | - | - |
Total Operating Expense | 1,593.25 | 1,528.87 | 1,567.26 | 1,519.69 |
Operating Income | 92.38 | -5.20 | 101.57 | 24.68 |
Interest Inc( Exp) Net- Non- Op Total | -871.42 | -809.67 | -680.57 | -830.43 |
Other Net | 13.03 | 3.34 | -8.84 | -26.27 |
Net Income Before Taxes | 18.27 | -42.42 | 34.08 | -84.77 |
Provisionfor Income Taxes | 13.27 | -18.24 | 9.03 | -11.50 |
Net Income After Taxes | 4.99 | -24.18 | 25.05 | -73.26 |
Net Income Before Extra Items | 4.99 | -24.18 | 25.05 | -73.26 |
Net Income | 4.99 | -24.18 | 25.05 | -73.26 |
Income Availableto Com Excl Extra Ord | 4.99 | -24.18 | 25.05 | -73.26 |
Income Availableto Com Incl Extra Ord | 4.99 | -24.18 | 25.05 | -73.26 |
Diluted Net Income | 4.99 | -24.18 | 25.05 | -73.26 |
Diluted Weighted Average Shares | 22.70 | 22.43 | 22.43 | 22.43 |
Diluted EPS Excluding Extra Ord Items | 0.22 | -1.08 | 1.12 | -3.27 |
Diluted Normalized EPS | 0.22 | -2.25 | 0.81 | -2.53 |
Unusual Expense( Income) | - | 0.00 | 0.00 | 25.32 |
Gain( Loss)on Saleof Assets | - | 404.08 | 94.07 | -1.31 |
Total Adjustmentsto Net Income | - | - | 0.01 | -0.01 |
DPS- Common Stock Primary Issue | - | - | - | 0.00 |
Nectar Lifesciences Dividend Nectar Lifesciences Bonus Nectar Lifesciences News Nectar Lifesciences AGM Nectar Lifesciences Rights Nectar Lifesciences Splits Nectar Lifesciences Board Meetings Nectar Lifesciences Key Metrics Nectar Lifesciences Shareholdings Nectar Lifesciences Balance Sheet Nectar Lifesciences Cashflow Nectar Lifesciences Q1 Results Nectar Lifesciences Q2 Results Nectar Lifesciences Q3 Results Nectar Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks